Get startedLog in
    Picture of BLS Pharmaceuticals logo

    BXNDA — BLS Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: Bioxyne Posts Revenue Of A$3.1 Million For Quarter

    Picture of BLS Pharmaceuticals logoBLS Pharmaceuticals
    30/07/2024 07:10
    July 30 (Reuters) - Bioxyne Ltd  BXN.AX :
    * REVENUE OF A$3.1 MILLION FOR QUARTER
    * DISCONTINUED ITS UNPROFITABLE DIRECT SALES OPERATIONS IN
ASIA


Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on BLS Pharmaceuticals

    See all news